| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |